Bionano Genomics, Inc. - BNGO Net Assets per Single Share

Graphic logo of Bionano Genomics (BNGO)

The trend in book value per share confirms the environmental responsibility of Bionano Genomics, Inc. (BNGO) in its production. However, global political tensions and export controls hinder the sale of systems, while pressure from sequencing leaders creates market risks. The value of 2.68 shows the current volume of the metric, demonstrating the company's level of net assets minus all liabilities.

Bionano Genomics, Inc. (BNGO) Equity per Share: for the period 07/04/2022 - 10/28/2026
Manufactured products of Bionano Genomics Inc.

Bionano Genomics, Inc. (BNGO) is optimizing costs through the outsourcing of production and logistics, which directly impacts its equity structure. By analyzing the book value per common share, an investor determines the actual value of net assets minus liabilities, filtering out market noise and speculative price volatility. The rising trend of this metric confirms the fundamental stability of the business and the objective value of the company's assets.

Competitor analysis for Bionano Genomics, Inc.

Book Value per Share TEM|QGEN: Book Value of One Share|Net Assets per Single Share IONS|repligen.com (RGEN) - Net Asset Value per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|Book Value per Share sarepta.com SRPT|TWST - Book Value per Share|TXG - Net Assets per Single Share|Intellia - Book Value per Share|STOK (Stoke Corp) - Net Assets per Share|Net Assets per Single Share BLFS (BioLife Solutions, Inc.)|Net Asset Value per Share WVE|Net Assets per Single Share Maze Therapeutics MAZE|Equity per Share Sionna Therapeutics, Inc. (SION)|Book Value per Share PRME (Prime Medicine Corp)|Taysha Corp - Book Value per Share|uniQure N.V. (QURE) - Net Assets per Single Share|MGTX: Equity per Share|Net Assets per Single Share RGNX|Net Asset Value per Share Solid Biosciences Inc|OCGN - Accounting Value per Share|Accounting Value of a Share PacBio Corp|BNTC: Book Value per Share|Book Value of One Share designtx.com (DSGN)|RCKT: Book Value per Share|4DMT - Net Asset Value per Share|Lexeo (LXEO) - Net Assets per Single Share|KRRO: Equity per Share|Net Assets per Single Share EDIT|SLN (silence-therapeutics.com) - Net Asset Value per Share|Net Assets per Single Share PRQR|Accounting Value per Share Codexis Bio|SGMO (Sangamo) - Book Value per Share|Net Assets per Share nautilus.bio (NAUT)|Metagenomi, Inc. - Book Value per Share|Precision BioSciences Inc. - Accounting Value per Share|Net Assets per Single Share GBIO (Generation Bio Corp)|Boundless Bio Inc. (BOLD) - Net Assets per Share|Accounting Value per Share exicuretx.com XCUR|Imunon (IMNN) - Accounting Value of a Share|PHIO: Book Value per Share|Net Assets per Share MBIO|Net Assets per Single Share TransCode Therapeutics RNAZ|Equity per Share Applied DNA Sciences Inc (APDN)|Bluebird Bio - Book Value per Share|IPA - Accounting Value per Share|Accounting Value per Share OMGA (Omega Therapeutics)|OMIC - Net Assets per Share|Regulus Therapeutics Inc. (RGLS) - Book Value per Share|SYRS (Syros Pharmaceuticals Inc.) - Net Assets per Single Share|Net Assets per Single Share Codex DNA (TBIO)|Equity per Share TRACON Pharmaceuticals, Inc|UBX: Book Value per Share